Blar i Institutt for klinisk og molekylær medisin på tidsskrift "Osteoporosis International"
Viser treff 1-5 av 5
-
Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway
(Journal article; Peer reviewed, 2018)Summary Use of anti-osteoporotic drugs (AODs) was examined in a Norwegian population 50–85 years. Among them with Fracture Risk Assessment Tool (FRAX) score for major osteoporotic fracture ≥ 20, 25% of the women and 17% ... -
Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway
(Peer reviewed; Journal article, 2021)Summary Bisphosphonates reduce fractures in randomized controlled trials (RCT); however, there is less information from real life. In our population including 14,990 women and 13,239 men, use of bisphosphonates reduced ... -
Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment
(Journal article; Peer reviewed, 2016)Summary This study examined musculoskeletal health in amphetamine users, compared with healthy age-matched controls. We show that amphetamine users have reduced bone mass at several skeletal sites and attenuated maximal ... -
Proton pump inhibitors and fracture risk. The HUNT study, Norway.
(Journal article; Peer reviewed, 2019)Summary Proton pump inhibitors (PPIs) have been linked to increased risk of fracture; the data have, however, been diverging. We did not find any increased risk of fractures among users of PPIs in a Norwegian population ... -
Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway
(Journal article; Peer reviewed, 2017)Summary Fracture Risk Assessment Tool (FRAX) without bone mineral density (BMD) for hip fracture prediction was validated in a Norwegian population 50–90 years. Fracture risk increased with higher FRAX score, and the ...